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ABSTRACT
Objective: This study was designed to explore the preliminary phytochemical and physicochemical analysis of Inai (Lawsonia inermis L.) leaves and 
further evaluation of its antihyperglycemic effect on diabetic rats from its active fraction.
Methods: The study begins with making the powder of Inai (L. inermis L.) leaves and then evaluates the physicochemical characterization. The 
powder of Inai leaves was fractionated and performed by the standard phytochemical screening method and streptozotocin-induced diabetic mice for 
evaluated the antihyperglycemic effect of Inai leaves.
Result: The physicochemical evaluation showed that the powder of Inai leaves has a good and high purity level; while the phytochemical screening 
showed that Inai leaves fractions have various phytoconstituents. The active fraction which was obtained from ethyl acetate fraction showed a 
significant reduction of the blood glucose.
Conclusion: The leaves of Inai (L. inermis L.) have the antihyperglycemic activity.
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INTRODUCTION
Diabetes mellitus (DM) is a disease or disorder of chronic metabolism with 
various etiologies characterized by high blood sugar (hyperglycemia) with 
carbohydrate, lipid, and protein metabolism due to insulin insufficiency 
function [1]. The state of chronic hyperglycemia will cause tissue damage 
such as kidney damage, retinal nerves, and cardiovascular vessels [2]. It 
is associated to long-term damage of various organs such as eyes, liver, 
kidneys, nerves, and blood vessels and it may cause degenerative diseases 
in central nervous system [3]. The prevalence of diabetes is projected to 
rise from 171 million in 2000 to 366 million in 2030 [4].
Nowadays, there is a global increase in the prevalence of DM related to 
the lifestyles and the resulting surge from in obesity [5]. Reasons for this 
rise are sedentary lifestyle, obesity, consumption of high energy rich 
diet, higher lifespan, etc. [6]. The most majority of these cases will be 
Type 2 DM (non-insulin-dependent DM) [7]. In spite of the availability 
of various antidiabetic agents and its secondary complications continue 
to become a major problem in the world population, medicinal plants 
and their extracts or fractions have an ancient background in this 
issue and used as an alternative method to treat the diabetes patient 
throughout the world and popular as nutraceutical [8,9].
One plant that is widely used as a traditional medicine is Inai (Lawsonia 
inermis L.). The leaves, flowers, seeds, stem bark, and plant roots have 
the potential to cure headaches, arthritis, diarrhea, and fever [10]. This 
plant is known throughout the world as a cosmetic ingredient used for 
hair dye, nails, and leather [11]. Among the people, stew leaves used 
as a medicine to relieve itching and ulcers that are suspected due to 
increased blood sugar levels. In addition, the leaf is also used by certain 
rural communities in Indonesia as a skin wound healer [12,13].
Based on various research results, Inai plant exhibits various 
pharmacological activities such as antibacterial, anti-irritant, 
antioxidant, antihyperglycemia, anti-inflammatory, analgesic, 
antipyretic, anticoagulant, and inotropic activity [14,15]. The 
antihyperglycemic effect of Inai leaves has been previously described for 
its leaves ethanolic extract [12]; nevertheless, the available information 
regarding the leaves is incomplete. The present study was designed 
to perform physicochemical and phytochemical analyses of Inai 
(L. inermis L.) and to evaluate its active fraction for antihyperglycemic 
activity in streptozotocin (STZ)-induced diabetic mice.
METHODS
Plant collection and identification
Fresh Inai (L. inermis L.) was collected from the city of Langsa (Aceh, 
Indonesia) and authenticated by the Indonesian Institute of Sciences: 
Research Center For Biology (No: 2534/IPH.1.01/If.07/XII/2015). The 
dried leaves samples were crushed and grounded to obtain a finely 
divided powder.
Preparation of fractions
Ethanolic extract of the powder was obtained by maceration method 
for 7 days followed by filtration. The ethanolic solvent was evaporated 
on rotary evaporator to obtain crude ethanolic extract and dried using 
freeze dryer to get dried crude ethanolic extract. The ethanolic extract 
was suspended in distilled water and partitioned with hexane, ethyl 
acetate, and water to obtain fractions of these solvents. The solvents 
were removed on rotary evaporator to obtain dried fractions [16,17].
Physicochemical evaluation
Analysis of physicochemical constants of the Inai leaves powder and 
ethanolic extracts has been done to evaluate the quality and purity of 
the herbal drugs. Various physicochemical parameters such as total 
ash value, acid-insoluble ash value, moisture content, alcohol, and 
water-soluble extractive value were calculated as per the World Health 
Organization (WHO) and Indonesia Materia Medika Guidelines [18,19].
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Preliminary phytochemical screening
Phytochemical screening carried out on Inai leaves hexane fraction, 
ethyl acetate fraction, and water fraction, including examing the 
chemical metabolites constituent of alkaloids, flavonoids, glycosides, 
saponins, tannins, triterpenoids, and steroids [20,21].
Preparation of animals
Healthy adult male mice (20–30 g body weight) from animal house of 
Faculty of Pharmacy, University of Sumatera Utara, were used for the 
study. The use of animals was approved by “Animal Research Ethics 
Committees (ARECs) of University of Sumatera Utara (AREC Reg. No: 
415/KEPH-FMIPA/2017).” Mice were housed in polycarbonate cages 
under room temperature (20 ± 2°C), relative humidity (60–70%) and 
were exposed to 12 h day-night circle. They were fed on a standard 
pellet diet and water ad libitum.
Oral glucose tolerance test
The oral glucose tolerance test was performed in overnight fasted (18 h) 
normal mice. Healthy mice were randomly selected and distributed into 
five groups (n=6). One of those groups was administered carboxymethyl 
cellulose (CMC) 5% and the four groups were given orally glibenclamide 
(0.65 mg/kg bw), hexane fraction, ethyl acetate fraction, and water 
fraction of Inai (L. inermis L.) with 600 mg/kg bw, respectively. 1% glucose 
was fed 1 h after the administration of fractions and glibenclamide. Blood 
was withdrawn from the tail vein at 30, 60, 90, and 120 min of glucose 
administration and glucose levels were estimated using a blood glucose 
monitoring kit. The most active fraction decreases blood glucose level 
which obtained from analyzed result will be used for further experiment.
Experimental design for antihyperglycemic activity
Experimental diabetes was induced by single intraperitoneal injection 
of 55 mg/kg of STZ, freshly dissolved in citrate buffer (pH 4.5). After 
3 days of STZ injection, mice with fasting glucose above 200 mg/dl were 
considered as diabetic and included in the study (Fazrina).
The animals were divided into five groups of three animals for each 
group was used in this experiment:
Group I: Normal control animals given normal pellet and CMC 0.5% b/v.
Group II: STZ-induced mice.
Group III: Mice were induced by STZ and treated with glybenclamide 
(0.65 mg/kg).
Group IV: Mice were induced by STZ and treated with ethyl acetate 
fraction (600 mg/kg).
The extract was given daily through oral way for 15 days.
Statistical analysis
All the values were determined by triplicates and expressed as mean 
± standard error of mean. The significant difference of data between 
different groups was compared by ANOVA followed by Duncan’s test.
RESULTS
Physicochemical evaluation
Table 1 summarizes the result of physicochemical evaluation from Inai 
(L. inermis L.) leaves powder and ethanol extract.
Phytochemical screening of Inai (L. inermis L.) fractions
Screening results of Inai (L. inermis L.) leaves fractions showed different 
chemical compound in different fraction. The results can be seen in Table 2.
Oral glucose tolerance test
The oral glucose tolerance test was comparable to that of the standard 
antidiabetic drug, glibenclamide. Maximum effect was observed for 
ethyl acetate fraction. The results can be seen in Table 3 and Fig. 1.
Effect of Inai leaves ethyl acetate fraction on diabetic mice
STZ-induced diabetic mice significantly increased the blood glucose 
level as shown in Table 4. The antihyperglycemic effect of Inai leaves 
ethyl acetate fraction at dose 600 mg/kg was studied in diabetic mice. 
Table 4 and Fig. 2 show the level of blood glucose at various intervals to 
observe the effect of different treatment using pumpkin flesh and seeds 
extracts and metformin.
DISCUSSION
The result of physicochemical properties evaluation shows that the 
powder and the ethanolic extracts were made with a good quality and 
high purity level, which accepted by the WHO. The most important 
parameter of physicochemical is the value of moisture. The less value of 
moisture content could prevent bacterial, fungal, and yeast growth so 
the quality will be good for a long of time [22].
The phytochemical screening investigation of different fractions of 
Inai (L. inermis L.) results shows that Inai leaves fractions revealed 
the presence of alkaloids, flavonoids, glycosides, saponins, tannins, 
steroids, and terpenoids (Table 2). Many of these phytochemical 
Table 1: Physicochemical evaluation result of Inai leaves powder and ethanolic extract
Inai leaves Physicochemical evaluation
Moisture content (%) Total Ash value (%) Acid‑insoluble Ash (%) Extractive soluble values
Alcohol (%) Water (%)
Powder 7.3 5.49 0.82 14.30 21.96
Ethanolic extract 6.98 2.31 0.59 27.61 23.61
Fig. 1: The oral glucose tolerance test result
Fig. 2: Effect of Inai leaves ethyl acetate fraction on blood glucose 
level in diabetic mice (mg/dl)
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compounds have been shown to produce potent antihyperglycemic 
activity.
The evaluation of the effect of three fractions (hexane, ethyl acetate, 
and water) from Inai leaves revealed the result that the most potential 
antihyperglycemic activity. The ethyl acetate fraction from Inai leaves 
showed a significant decrease in the blood glucose levels of the mice. 
This potential effect of ethyl acetate fraction from Inai leaves might be 
achieved by facilitating insulin release in pancreatic β-cells, inhibiting 
glucose absorption in gut, stimulating glycogenesis, and protect 
the DNA from the oxidative damage, so it can resist the problem in 
β-cell [23-25].
CONCLUSIONS
These findings suggest that Inai (L. inermis L.) leaves have a potent 
antidiabetic activity in STZ-induced diabetic mice.
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